Status:
COMPLETED
Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Amyloid Angiopathy
Eligibility:
All Genders
55+ years
Brief Summary
The cerebral amyloïd angiopathy ( AAC) is a disease characterized by deposits of beta-amyloid peptids in the walls of the arteries of young and average calibre of the brain and the leptomeninx. The in...
Eligibility Criteria
Inclusion
- age\>55
- hospitalized in CAEN hospital and Paris St Joseph Hospital between 1st january 2011 and 31 december 2015 for cerebral haemorrhage with MRI images diagnosing cerebral amyloid angiopathy.
Exclusion
- Insufficient MRI images quality without FLAI sequence, T2 GRE
- disease with same radiologic and clinical signs that cerebral amyloid angiopathy.
Key Trial Info
Start Date :
June 2 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT03262246
Start Date
June 2 2016
End Date
December 31 2018
Last Update
February 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France, 75014